As of Jun 19
| -14.64 / -30.58%|
The 4 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 28.00, with a high estimate of 35.00 and a low estimate of 15.00. The median estimate represents a -15.76% decrease from the last price of 33.24.
The current consensus among 6 polled investment analysts is to Hold stock in PTC Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.